GLP-1 Agonists and Suicidal Ideation: The Evidence GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda) are widely prescribed for type 2 diabetes and obesity management
Byetta is not insulin and should not be used as a substitute for insulin The safety and efficacy of Byetta in individuals younger than 18 years of age has not been studied Side Effects Like all medications, Byetta may have unwanted side effects for some people
Re-evaluate in 812 weeks
transitioning to monthly maintenance dosing at that point preserves most of the metabolic benefit while reducing treatment burden
S7D ), while both food intake and body weight decreased significantly under tirzepatide administration ( Fig
From a pharmacy and regulatory perspective, what will be just as important as the therapy itself is how platforms operationalize this at scaleensuring appropriate patient selection, monitoring, and state-by-state compliance as demand continues to surge